KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $172 | -48.0% | 14,467 | -57.9% | 0.00% | -66.7% |
Q3 2023 | $331 | +17.8% | 34,393 | +10.3% | 0.00% | +50.0% |
Q2 2023 | $281 | -99.9% | 31,180 | +62.6% | 0.00% | -60.0% |
Q3 2021 | $335,000 | +112.0% | 19,173 | +41.0% | 0.01% | -16.7% |
Q3 2019 | $158,000 | -76.3% | 13,600 | -41.5% | 0.01% | -88.0% |
Q1 2019 | $666,000 | – | 23,253 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,579,490 | $20,146,000 | 22.25% |
Novo Holdings A/S | 2,901,927 | $22,664,000 | 2.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 322,436 | $2,518,000 | 0.96% |
Vivo Capital, LLC | 300,325 | $2,346,000 | 0.69% |
VHCP Management II, LLC | 221,651 | $1,635,000 | 0.67% |
RA Capital Management | 591,070 | $4,616,000 | 0.57% |
INTERWEST VENTURE MANAGEMENT CO | 329,942 | $2,577,000 | 0.55% |
Eventide Asset Management | 98,100 | $766,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 21,665 | $169,000 | 0.03% |
A.R.T. Advisors, LLC | 11,116 | $86,000 | 0.00% |